The role of passive immunization in the age of SARS-CoV-2: an update

Johannes C. Fischer, Kurt Zanker, Martijn van Griensven, Marion Schneider, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Artur Lichtenberg, Balint Tamaskovics, Freddy Joel Djiepmo-Njanang, Wilfried Budach, Stefanie Corradini, Ute Ganswindt, Dieter Haeussinger, Torsten Feldt, Hubert Schelzig, Hans Bojar, Matthias Peiper, Edwin Boelke*, Jan Haussmann, Christiane Matuschek

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review


The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.

Original languageEnglish
Article number16
Number of pages6
JournalEuropean Journal of Medical Research
Issue number1
Publication statusPublished - 13 May 2020


  • Bridge therapy
  • Convalescent plasma
  • Covid-19
  • High risk
  • Immunology
  • Intensive care unit
  • Respiratory failure
  • COVID-19

Cite this